BACKGROUND: Dilated cardiomyopathy (DCM), which is characterized by left ventricular enlargement and systolic dysfunction, is divided into cases with a clear predisposing condition (eg, hypothyroidism, chemotherapeutic agents, alcoholism, ischemia) and those of unknown cause (idiopathic DCM). Many cases (20%-35%) of DCM are familial, implicating a genetic contribution to the etiology. More than 30 genes have been identified, many involving "private" mutations not shared among families. Evidence suggests that nonfamilial cases also have a genetic predisposition, again involving many genes. The goal of this study was to identify mutations in genes associated with DCM in a Québec study sample including familial and nonfamilial DCM cases. HYPOTHESIS: A prioritized gene study conducted within a framework for the classification of identified genetic variants could yield etiological information even in the absence of family data. METHODS: We sequenced 4 previously identified genes: lamin A/C (LMNA), cardiac troponin T type 2 (TNNT2), titin-cap (TCAP), and phospholamban (PLN). RESULTS: We discovered a nonsense mutation in the LMNA gene and a frameshift mutation in the TNNT2 gene, as well as other clinically significant variants that were not observed in publicly available databases or in Québec-based controls. PLN was sequenced to investigate a previously published promoter variant. However, our data confirm that this variant does not have a causal role in DCM. CONCLUSIONS: Despite high locus and allele heterogeneity, we demonstrate that a prioritized gene study, combined with next-generation exome-sequencing data, can be fruitful for the identification of DCM mutations.
BACKGROUND:Dilated cardiomyopathy (DCM), which is characterized by left ventricular enlargement and systolic dysfunction, is divided into cases with a clear predisposing condition (eg, hypothyroidism, chemotherapeutic agents, alcoholism, ischemia) and those of unknown cause (idiopathic DCM). Many cases (20%-35%) of DCM are familial, implicating a genetic contribution to the etiology. More than 30 genes have been identified, many involving "private" mutations not shared among families. Evidence suggests that nonfamilial cases also have a genetic predisposition, again involving many genes. The goal of this study was to identify mutations in genes associated with DCM in a Québec study sample including familial and nonfamilial DCM cases. HYPOTHESIS: A prioritized gene study conducted within a framework for the classification of identified genetic variants could yield etiological information even in the absence of family data. METHODS: We sequenced 4 previously identified genes: lamin A/C (LMNA), cardiac troponin T type 2 (TNNT2), titin-cap (TCAP), and phospholamban (PLN). RESULTS: We discovered a nonsense mutation in the LMNA gene and a frameshift mutation in the TNNT2 gene, as well as other clinically significant variants that were not observed in publicly available databases or in Québec-based controls. PLN was sequenced to investigate a previously published promoter variant. However, our data confirm that this variant does not have a causal role in DCM. CONCLUSIONS: Despite high locus and allele heterogeneity, we demonstrate that a prioritized gene study, combined with next-generation exome-sequencing data, can be fruitful for the identification of DCM mutations.
Authors: H B Wiles; P D McArthur; A B Taylor; P C Gillette; D A Fyfe; J P Matthews; L W Shelton Journal: Am J Cardiol Date: 1991-11-15 Impact factor: 2.778
Authors: L Mestroni; C Rocco; D Gregori; G Sinagra; A Di Lenarda; S Miocic; M Vatta; B Pinamonti; F Muntoni; A L Caforio; W J McKenna; A Falaschi; M Giacca Journal: J Am Coll Cardiol Date: 1999-07 Impact factor: 24.094
Authors: Elham Kayvanpour; Farbod Sedaghat-Hamedani; Ali Amr; Alan Lai; Jan Haas; Daniel B Holzer; Karen S Frese; Andreas Keller; Katrin Jensen; Hugo A Katus; Benjamin Meder Journal: Clin Res Cardiol Date: 2016-08-30 Impact factor: 5.460
Authors: Tharini Sivasubramaniyam; Jiaqi Yang; Henry S Cheng; Alexandra Zyla; Angela Li; Rickvinder Besla; Idit Dotan; Xavier S Revelo; Sally Yu Shi; Helen Le; Stephanie A Schroer; David W Dodington; Yoo Jin Park; Min Jeong Kim; Daniella Febbraro; Isabelle Ruel; Jacques Genest; Raymond H Kim; Tak W Mak; Daniel A Winer; Clinton S Robbins; Minna Woo Journal: Sci Rep Date: 2021-02-25 Impact factor: 4.379
Authors: Zhi Liu; Margaret A Pericak-Vance; Pascal Goldschmidt-Clermont; David Seo; Liyong Wang; Tatjana Rundek; Gary W Beecham Journal: PLoS One Date: 2017-10-10 Impact factor: 3.240